Tianjin Chase Sun Pharmaceutical Co Ltd (300026) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Based on the latest financial reports, Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥153.30 Million ≈ $22.43 Million USD) by net assets (CN¥8.80 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Tianjin Chase Sun Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Tianjin Chase Sun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Tianjin Chase Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300026 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Tianjin Chase Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Chase Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Pret Composites SHE:002324	0.095x
A.F.P. Habitat SN:HABITAT	0.087x
Prudent Corporate Advisory Services Limited NSE:PRUDENT	0.133x
DOMS Industries Limited NSE:DOMS	0.046x
Jiangyin Jianghua Microelectronics Materials Co Ltd SHG:603078	0.030x
Xinjiang Machinery Research Inst SHE:300159	0.010x
Dynapack International Technology TWO:3211	0.098x
Weichai Heavy Machinery Co Ltd SHE:000880	0.131x

Annual Cash Flow Conversion Efficiency for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 300026 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.80 Billion ≈ $1.29 Billion	CN¥852.24 Million ≈ $124.71 Million	0.097x	-43.86%
2023-12-31	CN¥8.87 Billion ≈ $1.30 Billion	CN¥1.53 Billion ≈ $223.90 Million	0.173x	+95.92%
2022-12-31	CN¥8.46 Billion ≈ $1.24 Billion	CN¥745.35 Million ≈ $109.07 Million	0.088x	+78.85%
2021-12-31	CN¥7.95 Billion ≈ $1.16 Billion	CN¥391.60 Million ≈ $57.30 Million	0.049x	+85.09%
2020-12-31	CN¥7.39 Billion ≈ $1.08 Billion	CN¥196.66 Million ≈ $28.78 Million	0.027x	-12.96%
2019-12-31	CN¥7.07 Billion ≈ $1.03 Billion	CN¥216.10 Million ≈ $31.62 Million	0.031x	-48.22%
2018-12-31	CN¥6.58 Billion ≈ $962.28 Million	CN¥388.19 Million ≈ $56.81 Million	0.059x	-48.25%
2017-12-31	CN¥6.51 Billion ≈ $952.41 Million	CN¥742.38 Million ≈ $108.63 Million	0.114x	+53.72%
2016-12-31	CN¥6.04 Billion ≈ $883.64 Million	CN¥448.08 Million ≈ $65.57 Million	0.074x	+224.40%
2015-12-31	CN¥5.29 Billion ≈ $774.07 Million	CN¥121.00 Million ≈ $17.71 Million	0.023x	-64.02%
2014-12-31	CN¥2.36 Billion ≈ $345.13 Million	CN¥149.94 Million ≈ $21.94 Million	0.064x	-24.62%
2013-12-31	CN¥1.70 Billion ≈ $249.14 Million	CN¥143.60 Million ≈ $21.01 Million	0.084x	-23.17%
2012-12-31	CN¥1.39 Billion ≈ $202.91 Million	CN¥152.21 Million ≈ $22.27 Million	0.110x	+223.42%
2011-12-31	CN¥1.05 Billion ≈ $153.65 Million	CN¥35.64 Million ≈ $5.22 Million	0.034x	-19.44%
2010-12-31	CN¥1.10 Billion ≈ $160.63 Million	CN¥46.25 Million ≈ $6.77 Million	0.042x	-71.09%
2009-12-31	CN¥926.88 Million ≈ $135.63 Million	CN¥135.06 Million ≈ $19.76 Million	0.146x	-76.47%
2008-12-31	CN¥125.51 Million ≈ $18.37 Million	CN¥77.74 Million ≈ $11.38 Million	0.619x	-47.33%
2007-12-31	CN¥61.24 Million ≈ $8.96 Million	CN¥72.01 Million ≈ $10.54 Million	1.176x	+1943.30%
2006-12-31	CN¥21.28 Million ≈ $3.11 Million	CN¥1.22 Million ≈ $179.15K	0.058x	--

About Tianjin Chase Sun Pharmaceutical Co Ltd

SHE:300026 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.50 Billion

CN¥10.27 Billion CNY

Market Cap Rank

#7118 Global

#1486 in China

Share Price

CN¥3.42

Change (1 day)

+1.48%

52-Week Range

CN¥2.90 - CN¥4.33

All Time High

CN¥9.11